Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 335

Similar articles for PubMed (Select 10891024)

1.

The magnitude and challenge of false-positive newborn screening test results.

Kwon C, Farrell PM.

Arch Pediatr Adolesc Med. 2000 Jul;154(7):714-8.

PMID:
10891024
2.
3.

State screening for metabolic disorders in newborns.

Stevens MB, Rigilano JC, Wilson CC.

Am Fam Physician. 1988 Apr;37(4):223-8.

PMID:
3358346
4.

[Screening for congenital hypothyroidism, phenylketonuria, galactosemia and biotinidase deficiency in a sample of mentally retarded patients in the city of Havana].

Marrero-González N, Portuondo-Sao M, Lardoeyt-Ferrer R, Tassé-Vila D, Lantigua-Cruz A.

Rev Neurol. 2003 May 16-31;36(10):913-6. Spanish.

5.

Screening for metabolic disorders. How are we doing?

Irons M.

Pediatr Clin North Am. 1993 Oct;40(5):1073-85. Review.

PMID:
8414711
6.

Ethnic and gender patterns for the five congenital disorders in Texas from 1992 through 1998.

Strahan JE, Canfield MA, Drummond-Borg LM, Neill SU.

Tex Med. 2002 Sep;98(9):80-6.

PMID:
12271912
7.

Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.

Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A.

J Pediatr. 1997 Jan;130(1):128-33.

PMID:
9003862
8.

[National screening for phenylketonuria, congenital hypothyroidism and congenital adrenal hyperplasia].

Osório RV, Vilarinho L, Soares JP.

Acta Med Port. 1992 Mar;5(3):131-4. Portuguese.

9.

Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.

Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.

Pediatrics. 1996 Sep;98(3 Pt 1):362-7.

PMID:
8784357
10.
11.

Neonatal screening for biotinidase deficiency: results of a 1-year pilot study.

Heard GS, Wolf B, Jefferson LG, Weissbecker KA, Nance WE, McVoy JR, Napolitano A, Mitchell PL, Lambert FW, Linyear AS.

J Pediatr. 1986 Jan;108(1):40-6.

PMID:
3944695
12.

Neonatal screening in Europe; the situation in 2004.

Loeber JG.

J Inherit Metab Dis. 2007 Aug;30(4):430-8. Epub 2007 Jul 6. Erratum in: J Inherit Metab Dis. 2008 Jun;31(3):469.

PMID:
17616847
13.

Recent developments in neonatal screening.

Naylor EW.

Semin Perinatol. 1985 Apr;9(3):232-49. No abstract available.

PMID:
3832439
14.

Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.

Varness TS, Allen DB, Hoffman GL.

J Pediatr. 2005 Oct;147(4):493-8.

PMID:
16227036
15.

Adverse medical outcomes of early newborn screening programs for phenylketonuria.

Brosco JP, Sanders LM, Seider MI, Dunn AC.

Pediatrics. 2008 Jul;122(1):192-7. doi: 10.1542/peds.2007-3027. Review.

16.
17.

[Programs of systematic screening in neonatology. Pharmaco-economic aspects].

Schoos R, Verloes A, Bourguignon JP, Koulischer L.

Rev Med Liege. 1998 May;53(5):311-5. French.

PMID:
9689890
18.

Newborn screening for congenital adrenal hyperplasia.

Therrell BL.

Endocrinol Metab Clin North Am. 2001 Mar;30(1):15-30. Review.

PMID:
11344933
19.

Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.

Thil'en A, Nordenström A, Hagenfeldt L, von Döbeln U, Guthenberg C, Larsson A.

Pediatrics. 1998 Apr;101(4):E11.

PMID:
9521977
20.

Congenital adrenal hyperplasia: should nationwide screening be implemented in Thailand?

Janejai N, Krasao P, Phansang J, Pankarnjanato R, Charoensiriwatana W.

Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:170-3.

PMID:
15906728
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk